华体会app官网下载,华体会官网在线

华体会app官网下载
CN
CN EN
Devoted to the life sciences with persistence, Kexing Biopharm has focused on the innovation and industrialization of biopharmaceuticals,and established a relatively complete system of pharmaceutical R&D, covering pharmaceutical innovation capabilities from pharmaceutical discovery, pharmaceutical research, preclinical research and clinical research to industrialized production.

we have established a complete system of pharmaceutical R&D innovation, covering pharmaceutical innovation capabilities from pharmaceutical discovery, pharmaceutical research, preclinical research and clinical research to industrialized production. Depending on prokaryotic cell technology, eukaryotic cell technology and viable bacteria technology, we have built 5 world-leading technology platforms, including strain platform, recombinant protein therapeutics industrialization platform, microecological agent R&D and industrialization platform, recombinant protein secretion and expression platform and long-acting recombinant protein platform.

At present, we have obtained 38 patents, with 9 biopharmaceutical projects under research, including 3 projects of new biopharmaceuticals. An R&D team composed of nearly 170 members from the fields of molecular biology, pharmacy, pharmaceutics, etc., with core technicians engaged in R&D for more than 10 years.

医药研究院